Cosmetic Pterygium Surgery: Techniques and Long-Term Outcomes

Arun C Gulani, Aaishwariya A Gulani Gulani Vision Institute, Jacksonville, FL, USACorrespondence: Arun C GulaniGulani Vision Institute, 8075 Gate Parkway West Suite 102, Jacksonville, FL 32216, USATel +1 904 296 7393Fax +1888 650-0744Email gulanivision@gulani.comBackground: To demonstrate the long-t...

Full description

Bibliographic Details
Main Authors: Gulani AC, Gulani AA
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:Clinical Ophthalmology
Subjects:
Online Access:https://www.dovepress.com/cosmetic-pterygium-surgery-techniques-and-long-term-outcomes-peer-reviewed-article-OPTH
_version_ 1819015194450329600
author Gulani AC
Gulani AA
author_facet Gulani AC
Gulani AA
author_sort Gulani AC
collection DOAJ
description Arun C Gulani, Aaishwariya A Gulani Gulani Vision Institute, Jacksonville, FL, USACorrespondence: Arun C GulaniGulani Vision Institute, 8075 Gate Parkway West Suite 102, Jacksonville, FL 32216, USATel +1 904 296 7393Fax +1888 650-0744Email gulanivision@gulani.comBackground: To demonstrate the long-term results of enhanced cosmetic pterygium surgery with extensive Tenonectomy, adjunctive fibrin-glued amniotic membrane transplantation (AMT), and mitomycin C (MMC).Methods: Retrospective chart review of patients who had pterygium surgery with AMT and MMC between January 2001 to July 2017 and had completed at least 6 months of follow-up. Early and long-term postoperative cosmetic outcomes, recurrence rate, and complications were analyzed. Cosmetic outcomes were evaluated based on patient and surgeon reported outcome measures.Results: The study was conducted on a total of 603 eyes of 578 patients (316 males, 262 females) with an average age of 52.9 ± 15.1 years. At post-op day 1, patients reported no discomfort and could not tell which eye had surgery based on patient reported subjective grading scales. Over an average follow-up period of 23.1 ± 35 months (range: 6– 216 months), there was one pterygium recurrence (0.2%), eighteen granulomas (2.9%), one self-resolving scleral melt (0.2%), one correctable restricted ocular motility (0.2%), one pupil abnormality (0.2%), one dellen (0.2%) and one correctable upper lid abnormality (0.2%). Planned laser vision correction was used for residual corneal scar in eleven eyes (1.8%) as a staged refractive approach.Conclusion: This study highlights an improved technique of an old concept of pterygium surgery that not only reduces the recurrence but also enhances cosmetic excellence and improves the quality of vision.Keywords: amniotic membrane, mitomycin C, pterygium
first_indexed 2024-12-21T02:27:52Z
format Article
id doaj.art-a8b8ac40c99d45afa6f45f79abc39fb9
institution Directory Open Access Journal
issn 1177-5483
language English
last_indexed 2024-12-21T02:27:52Z
publishDate 2020-06-01
publisher Dove Medical Press
record_format Article
series Clinical Ophthalmology
spelling doaj.art-a8b8ac40c99d45afa6f45f79abc39fb92022-12-21T19:18:59ZengDove Medical PressClinical Ophthalmology1177-54832020-06-01Volume 141681168754620Cosmetic Pterygium Surgery: Techniques and Long-Term OutcomesGulani ACGulani AAArun C Gulani, Aaishwariya A Gulani Gulani Vision Institute, Jacksonville, FL, USACorrespondence: Arun C GulaniGulani Vision Institute, 8075 Gate Parkway West Suite 102, Jacksonville, FL 32216, USATel +1 904 296 7393Fax +1888 650-0744Email gulanivision@gulani.comBackground: To demonstrate the long-term results of enhanced cosmetic pterygium surgery with extensive Tenonectomy, adjunctive fibrin-glued amniotic membrane transplantation (AMT), and mitomycin C (MMC).Methods: Retrospective chart review of patients who had pterygium surgery with AMT and MMC between January 2001 to July 2017 and had completed at least 6 months of follow-up. Early and long-term postoperative cosmetic outcomes, recurrence rate, and complications were analyzed. Cosmetic outcomes were evaluated based on patient and surgeon reported outcome measures.Results: The study was conducted on a total of 603 eyes of 578 patients (316 males, 262 females) with an average age of 52.9 ± 15.1 years. At post-op day 1, patients reported no discomfort and could not tell which eye had surgery based on patient reported subjective grading scales. Over an average follow-up period of 23.1 ± 35 months (range: 6– 216 months), there was one pterygium recurrence (0.2%), eighteen granulomas (2.9%), one self-resolving scleral melt (0.2%), one correctable restricted ocular motility (0.2%), one pupil abnormality (0.2%), one dellen (0.2%) and one correctable upper lid abnormality (0.2%). Planned laser vision correction was used for residual corneal scar in eleven eyes (1.8%) as a staged refractive approach.Conclusion: This study highlights an improved technique of an old concept of pterygium surgery that not only reduces the recurrence but also enhances cosmetic excellence and improves the quality of vision.Keywords: amniotic membrane, mitomycin C, pterygiumhttps://www.dovepress.com/cosmetic-pterygium-surgery-techniques-and-long-term-outcomes-peer-reviewed-article-OPTHamniotic membranemitomycin cpterygium
spellingShingle Gulani AC
Gulani AA
Cosmetic Pterygium Surgery: Techniques and Long-Term Outcomes
Clinical Ophthalmology
amniotic membrane
mitomycin c
pterygium
title Cosmetic Pterygium Surgery: Techniques and Long-Term Outcomes
title_full Cosmetic Pterygium Surgery: Techniques and Long-Term Outcomes
title_fullStr Cosmetic Pterygium Surgery: Techniques and Long-Term Outcomes
title_full_unstemmed Cosmetic Pterygium Surgery: Techniques and Long-Term Outcomes
title_short Cosmetic Pterygium Surgery: Techniques and Long-Term Outcomes
title_sort cosmetic pterygium surgery techniques and long term outcomes
topic amniotic membrane
mitomycin c
pterygium
url https://www.dovepress.com/cosmetic-pterygium-surgery-techniques-and-long-term-outcomes-peer-reviewed-article-OPTH
work_keys_str_mv AT gulaniac cosmeticpterygiumsurgerytechniquesandlongtermoutcomes
AT gulaniaa cosmeticpterygiumsurgerytechniquesandlongtermoutcomes